“I am very annoyed”: Pharma execs blast RFK Jr.’s attack on vaccines - Ars Technica
Google News • 1/15/2026 – 1/17/2026
Summary
Pharmaceutical executives have expressed their annoyance at Robert F. Kennedy Jr.'s attacks on vaccines. The criticism highlights concerns about the impact of such statements on public perception and vaccine acceptance.
Advertisement
Lindy Score Breakdown (V4.2)
49d
Age
1
Sources
from cluster
1133
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1133/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1133/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (6/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 48 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Moderna to pay Roivant up to $2.25 billion to settle patent lawsuit behind mRNA vaccines
Stat News • 1 day ago
STAT+: Trump can’t break free from vaccine politics
Stat News • 1 day ago
STAT+: What does malpractice insurance have to do with AI?
Stat News • 1 day ago
STAT+: CMS halts enrollment in Elevance’s Medicare Advantage plans, citing years of misconduct
Stat News • 2 days ago
STAT+: A new mystery emerges about Epstein’s involvement in Harvard genetics study
Stat News • Today
STAT+: RFK Jr. has wide discretion to choose evidence to support vaccine decisions, DOJ argues
Stat News • Today
STAT+: CMS wants more drugmakers to join Medicaid ‘most-favored nations’ pilot
Stat News • 2 days ago
STAT+: Pharmalittle: We’re reading about Moderna’s $2.25 billion settlement, FDA warning letters, and more
Stat News • 1 day ago
STAT+: Prime Medicine to seek approval for gene editing treatment after two-patient trial
Stat News • 1 day ago
STAT+: FDA warns more telehealth firms about compounded GLP-1s
Stat News • 1 day ago